SYNERCID

This brand name is authorized in United States. It is also authorized in South Africa.

Active ingredients

The drug SYNERCID contains a combination of these active pharmaceutical ingredients (APIs):

1	Quinupristin UNII 23OW28RS7P - QUINUPRISTIN
	Read more about Quinupristin
2	Dalfopristin UNII R9M4FJE48E - DALFOPRISTIN
	Read more about Dalfopristin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SYNERCID Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FG02	Quinupristin/dalfopristin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FG Streptogramins
Discover more medicines within J01FG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	61570-260
ZA	Health Products Regulatory Authority	35/20.1.1/0006